Nuclear S100A4 is a novel prognostic marker in colorectal cancer
Authors:
- 18 August 2010
- journal article
- research article
- Published by Elsevier in European Journal of Cancer
- Vol. 46 (16) , 2919-2925
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- S100A4 and MetastasisThe American Journal of Pathology, 2010
- Is adjuvant therapy for stage II colon cancer worthwhile, and for whom?Nature Clinical Practice Gastroenterology & Hepatology, 2008
- Metastasis-associated protein S100A4—a potential prognostic marker for colorectal cancerJournal of Surgical Oncology, 2006
- Adjuvant therapy in colon cancer—what, when and how?Annals of Oncology, 2006
- S100A4, a Mediator of MetastasisJournal of Biological Chemistry, 2006
- Colon Cancer Survival Rates With the New American Joint Committee on Cancer Sixth Edition StagingJNCI: Journal of the National Cancer Institute, 2004
- American Society of Clinical Oncology Recommendations on Adjuvant Chemotherapy for Stage II Colon CancerJournal of Clinical Oncology, 2004
- Nuclear localization of the metastasis‐related protein S100A4 correlates with tumour stage in colorectal cancerThe Journal of Pathology, 2003
- Intracellular and extracellular roles of S100 proteinsMicroscopy Research and Technique, 2003
- Prognostic significance of calcium-binding protein S100A4 in colorectal cancerGastroenterology, 2002